Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients

NCT07215754 · clinicaltrials.gov ↗
RECRUITING
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Pisa